Global Cryopreserved Hepatocytes Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Cryopreserved Hepatocytes Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Cryopreserved hepatocytes as an in vitro tool for generating physiologically relevant results
Cryopreserved Hepatocytes report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cryopreserved Hepatocytes market is projected to reach US$ 797.4 million in 2033, increasing from US$ 565 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Demand from Cell/Molecular Biology and Virology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cryopreserved Hepatocytes industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Cryopreserved Hepatocytes key manufacturers include Corning, Thermo Fisher Scientific, Tocris Bioscience, LONZA, Cytes Biotechnologies, BioIVT, XenoTech, Sunncell and Atlantis Bioscience Pte Ltd, etc. Corning, Thermo Fisher Scientific, Tocris Bioscience are top 3 players and held % sales share in total in 2022.
Cryopreserved Hepatocytes can be divided into Human Hepatocytes and Animal Liver Cells, etc. Human Hepatocytes is the mainstream product in the market, accounting for % sales share globally in 2022.
Cryopreserved Hepatocytes is widely used in various fields, such as Cell/Molecular Biology, Virology and Other,, etc. Cell/Molecular Biology provides greatest supports to the Cryopreserved Hepatocytes industry development. In 2022, global % sales of Cryopreserved Hepatocytes went into Cell/Molecular Biology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cryopreserved Hepatocytes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Corning
Thermo Fisher Scientific
Tocris Bioscience
LONZA
Cytes Biotechnologies
BioIVT
XenoTech
Sunncell
Atlantis Bioscience Pte Ltd
PRIMACYT Cell Culture Technology GmbH
Discovery
MB Biosciences
Segment by Type
Human Hepatocytes
Animal Liver Cells
Cell/Molecular Biology
Virology
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cryopreserved Hepatocytes market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cryopreserved Hepatocytes, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cryopreserved Hepatocytes industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Cryopreserved Hepatocytes in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cryopreserved Hepatocytes introduction, etc. Cryopreserved Hepatocytes Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Cryopreserved Hepatocytes market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Cryopreserved Hepatocytes report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cryopreserved Hepatocytes market is projected to reach US$ 797.4 million in 2033, increasing from US$ 565 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Demand from Cell/Molecular Biology and Virology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cryopreserved Hepatocytes industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Cryopreserved Hepatocytes key manufacturers include Corning, Thermo Fisher Scientific, Tocris Bioscience, LONZA, Cytes Biotechnologies, BioIVT, XenoTech, Sunncell and Atlantis Bioscience Pte Ltd, etc. Corning, Thermo Fisher Scientific, Tocris Bioscience are top 3 players and held % sales share in total in 2022.
Cryopreserved Hepatocytes can be divided into Human Hepatocytes and Animal Liver Cells, etc. Human Hepatocytes is the mainstream product in the market, accounting for % sales share globally in 2022.
Cryopreserved Hepatocytes is widely used in various fields, such as Cell/Molecular Biology, Virology and Other,, etc. Cell/Molecular Biology provides greatest supports to the Cryopreserved Hepatocytes industry development. In 2022, global % sales of Cryopreserved Hepatocytes went into Cell/Molecular Biology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cryopreserved Hepatocytes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Corning
Thermo Fisher Scientific
Tocris Bioscience
LONZA
Cytes Biotechnologies
BioIVT
XenoTech
Sunncell
Atlantis Bioscience Pte Ltd
PRIMACYT Cell Culture Technology GmbH
Discovery
MB Biosciences
Segment by Type
Human Hepatocytes
Animal Liver Cells
Segment by Application
Cell/Molecular Biology
Virology
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cryopreserved Hepatocytes market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cryopreserved Hepatocytes, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cryopreserved Hepatocytes industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Cryopreserved Hepatocytes in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cryopreserved Hepatocytes introduction, etc. Cryopreserved Hepatocytes Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Cryopreserved Hepatocytes market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.